Everpoint Asset Management buys $42,817,259 stake in Acadia Healthcare Company Inc (ACHC)

Acadia Healthcare Company Inc (ACHC) : Everpoint Asset Management scooped up 760,631 additional shares in Acadia Healthcare Company Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 1,095,631 shares of Acadia Healthcare Company Inc which is valued at $42,817,259.Acadia Healthcare Company Inc makes up approximately 1.03% of Everpoint Asset Management’s portfolio.

Other Hedge Funds, Including , Quantum Capital Management added ACHC to its portfolio by purchasing 94,294 company shares during the most recent quarter which is valued at $3,685,010. Acadia Healthcare Company Inc makes up approx 1.00% of Quantum Capital Management’s portfolio.Keybank National Associationoh boosted its stake in ACHC in the latest quarter, The investment management firm added 335 additional shares and now holds a total of 4,639 shares of Acadia Healthcare Company Inc which is valued at $183,148.Blackrock Investment Management boosted its stake in ACHC in the latest quarter, The investment management firm added 703 additional shares and now holds a total of 34,944 shares of Acadia Healthcare Company Inc which is valued at $1,370,853. Capital Fund Management S.a. added ACHC to its portfolio by purchasing 31,439 company shares during the most recent quarter which is valued at $1,109,797. Acadia Healthcare Company Inc makes up approx 0.02% of Capital Fund Management S.a.’s portfolio.

Acadia Healthcare Company Inc opened for trading at $38.25 and hit $39 on the upside on Monday, eventually ending the session at $38.58, with a gain of 0.63% or 0.24 points. The heightened volatility saw the trading volume jump to 10,68,707 shares. Company has a market cap of $3,376 M.

On the company’s financial health, Acadia Healthcare Company Inc reported $0.58 EPS for the quarter, based on the information available during the earnings call on Nov 1, 2016. Analyst had a consensus estimate of $0.58. The company had revenue of $734.67 million for the quarter, compared to analysts expectations of $735.39 million. The company’s revenue was up 53.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.

Many Wall Street Analysts have commented on Acadia Healthcare Company Inc. Shares were Reiterated by Mizuho on Nov 3, 2016 to “Buy” and Lowered the Price Target to $ 45 from a previous price target of $71 .Acadia Healthcare Company Inc was Upgraded by Raymond James to ” Strong Buy” on Nov 3, 2016. Shares were Reiterated by RBC Capital Mkts on Oct 19, 2016 to “Outperform” and Lowered the Price Target to $ 59 from a previous price target of $78 .

Acadia Healthcare Company Inc. is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities residential treatment centers group homes substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities. It operates in two segments: U.S. Facilities and U.K. Facilities. Its U.S. Facilities and services are classified into categories which includes acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. In the United Kingdom it provides inpatient services through mental health hospitals and care homes. In addition to these services it also operates a U.K. division to provide EAP to organizations. The Company operated approximately 78 behavioral healthcare facilities with over 5800 beds in approximately 24 states the United Kingdom and Puerto Rico.

Leave a Reply

Acadia Healthcare Company Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Acadia Healthcare Company Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.